Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage

Clinical trial NCT05369351 · RECRUITING

Trial details

NCT number: NCT05369351
Sponsor: Tianjin Medical University General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intracerebral Haemorrhage

Start date: 2024-01-17
Primary completion: 2026-08-10
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.